These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11914600)

  • 1. Prognostic impact of multiple allelic losses on metastatic recurrence in hepatocellular carcinoma after curative resection.
    Nishida N; Fukuda Y; Komeda T; Ito T; Nishimura T; Minata M; Kuno M; Katsuma H; Ikai I; Yamaoka Y; Nakao K
    Oncology; 2002; 62(2):141-8. PubMed ID: 11914600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
    Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
    Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma.
    Nishida N; Fukuda Y; Kokuryu H; Sadamoto T; Isowa G; Honda K; Yamaoka Y; Ikenaga M; Imura H; Ishizaki K
    Int J Cancer; 1992 Jul; 51(6):862-8. PubMed ID: 1322376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
    Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
    J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
    Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
    Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclin D1, cyclin E, cdk4 and loss of heterozygosity of 8p, 13q, 17p in hepatocellular carcinoma: comparison study of childhood and adult hepatocellular carcinoma.
    Kim H; Lee MJ; Kim MR; Chung IP; Kim YM; Lee JY; Jang JJ
    Liver; 2000 Apr; 20(2):173-8. PubMed ID: 10847487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
    Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
    Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic significance of loss of heterozygosity in breast cancer].
    Iwase H; Iwata H; Toyama T; Hara Y; Omoto Y; Kobayashi S
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():426-30. PubMed ID: 9589047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of frequent allelic loss on 17p13.1 with early metastatic recurrence of hepatocellular carcinoma after liver transplantation.
    Zhou L; Zhou W; Wu L; Yu X; Xing C; Zheng S
    J Surg Oncol; 2010 Dec; 102(7):802-8. PubMed ID: 20886556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China.
    Li SP; Wang HY; Li JQ; Zhang CQ; Feng QS; Huang P; Yu XJ; Huang LX; Liang QW; Zeng YX
    J Hepatol; 2001 Jun; 34(6):840-9. PubMed ID: 11451167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
    Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
    Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma.
    Niu Q; Tang ZY; Qin LX; Ma ZC; Zhang LH
    Hepatogastroenterology; 2003; 50(53):1579-82. PubMed ID: 14571790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genome-wide loss of heterozygosity analyses in primary hepatocellular carcinoma].
    Li S; Wang H; Zhang C
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):577-81. PubMed ID: 11798820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis.
    Zhang LH; Qin LX; Ma ZC; Ye SL; Liu YK; Ye QH; Wu X; Huang W; Tang ZY
    J Cancer Res Clin Oncol; 2003 May; 129(5):279-86. PubMed ID: 12734753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
    Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
    Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cumulative allelic losses with tumor aggressiveness in hepatocellular carcinoma.
    Tamura S; Nakamori S; Kuroki T; Sasaki Y; Furukawa H; Ishikawa O; Imaoka S; Nakamura Y
    J Hepatol; 1997 Oct; 27(4):669-76. PubMed ID: 9365043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.
    Yu MC; Lee CW; Lee YS; Lian JH; Tsai CL; Liu YP; Wu CH; Tsai CN
    World J Gastroenterol; 2017 Nov; 23(44):7818-7829. PubMed ID: 29209123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity on 10q23 is involved in metastatic recurrence of hepatocellular carcinoma.
    Okuno T; Ueda M; Tsuruyama T; Haga H; Takada Y; Maetani Y; Tamaki K; Manabe T; Tanaka K; Uemoto S
    Cancer Sci; 2009 Mar; 100(3):520-8. PubMed ID: 19077004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelotype analysis of hepatocellular carcinoma.
    Piao Z; Park C; Park JH; Kim H
    Int J Cancer; 1998 Jan; 75(1):29-33. PubMed ID: 9426686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.